Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!

Range Low Price High Price Comment
30 days $28.71 $35.40 Friday, 10th May 2024 AGIO stock ended at $33.00. This is 0.243% more than the trading day before Thursday, 9th May 2024. During the day the stock fluctuated 1.97% from a day low at $32.45 to a day high of $33.09.
90 days $24.69 $35.48
52 weeks $19.80 $35.48

Historical Agios Pharmaceuticals prices

Date Open High Low Close Volume
Sep 16, 2016 $46.62 $46.62 $46.62 $46.62 1 187 900
Sep 15, 2016 $45.89 $45.89 $45.89 $45.89 2 220 700
Sep 14, 2016 $45.26 $45.26 $45.26 $45.26 948 200
Sep 13, 2016 $45.95 $45.95 $45.95 $45.95 713 400
Sep 12, 2016 $45.80 $45.80 $45.80 $45.80 929 200
Sep 09, 2016 $43.00 $43.00 $43.00 $43.00 1 116 500
Sep 08, 2016 $46.66 $46.66 $46.66 $46.66 942 700
Sep 07, 2016 $46.98 $46.98 $46.98 $46.98 4 739 300
Sep 06, 2016 $37.32 $37.32 $37.32 $37.32 405 300
Sep 02, 2016 $36.35 $36.35 $36.35 $36.35 296 800
Sep 01, 2016 $36.74 $36.74 $36.74 $36.74 245 000
Aug 31, 2016 $36.84 $36.84 $36.84 $36.84 484 700
Aug 30, 2016 $36.62 $36.62 $36.62 $36.62 802 300
Aug 29, 2016 $37.76 $37.76 $37.76 $37.76 305 100
Aug 26, 2016 $38.03 $38.03 $38.03 $38.03 585 500
Aug 25, 2016 $38.08 $38.08 $38.08 $38.08 914 400
Aug 24, 2016 $38.52 $38.52 $38.52 $38.52 904 300
Aug 23, 2016 $40.99 $40.99 $40.99 $40.99 506 300
Aug 22, 2016 $40.31 $40.31 $40.31 $40.31 698 900
Aug 19, 2016 $39.90 $39.90 $39.90 $39.90 375 800
Aug 18, 2016 $40.55 $40.55 $40.55 $40.55 406 100
Aug 17, 2016 $39.91 $39.91 $39.91 $39.91 368 600
Aug 16, 2016 $40.82 $40.82 $40.82 $40.82 411 100
Aug 15, 2016 $41.63 $41.63 $41.63 $41.63 534 100
Aug 12, 2016 $40.42 $40.42 $40.42 $40.42 584 900
Click to get the best stock tips daily for free!

About Agios Pharmaceuticals

Agios Pharmaceuticals Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines in the field of cellular metabolism and adjacent areas of biology. The company offers PYRUKYND (mitapivat) an activator of both wild-type and a variety of mutant pyruvate kinase, PK, enzymes for the treatment of hemolytic anemias; and AG-946 that is in Phase I clinical study for treating hemolytic anemias and other indications. Agios Ph... AGIO Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT